CD56 and CD11b Positivity with Low Smac/DIABLO Expression as Predictors of Chemoresistance in Acute Myeloid Leukaemia: Flow Cytometric Analysis
Conclusions: CD56 and CD11b positivity and low Smac/DIABLO expression are important predictive factors for
the occurrence of chemoresistance, in addition to other risk factors, among AML patients.
PMID: 30486609 [PubMed - in process]
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Asian Pac J Cancer Prev Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Genetics | Leukemia | Study